Title: Comment on: Use of plerixafor for short-term management of leukopenia in a pediatric patient with WHIM syndromeAuthors : Julia T. Warren1,2 │Christophe Arbet-Engels3 │ Deborah J. Steiner3│ Teresa K. Tarrant4,5Affiliations :1Department of Pediatrics, Division of Hematology, Perlman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; 2Division of Pediatric Hematology, Children’s Hospital of Philadelphia, Philadelphia, PA, USA; 3X4 Pharmaceuticals Inc, Boston, MA, USA; 4Department of Medicine, Division of Rheumatology and Immunology, Duke University, Durham, NC, USA; 5Department of Veteran Affairs, Durham Medical Hospital, Durham, NC, USACorresponding author : Teresa K. TarrantAddress : DUMC 3874, 236 Sands Dr., Durham, NC 27710Phone : 919-684-4499Fax : 919-684-8358Email : teresa.tarrant@duke.eduWord count : 498/500Figures/Tables : 1 figureRunning Title (50 characters or less) : CXCR4 Antagonism to Treat Warts in WHIM SyndromeKeywords : WHIM syndrome, CXCR4 antagonist, mavorixafor, neutropenia, warts